Dimensional Fund Advisors
BNR

Dimensional Fund Advisors’s Burning Rock Biotech BNR Stock Holding History

Dimensional Fund Advisors’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,902
Closed -$35.7K – 3380
2024
Q1 		$35.7K Hold
4,902
– – ﹤0.01% 3347
2023
Q4 		$45.6K Sell
4,902
-595
-11% -$5.47K ﹤0.01% 3356
2023
Q3 		$53.3K Sell
5,497
-593
-10% -$9.26K ﹤0.01% 3376
2023
Q2 		$133K Hold
6,090
– – ﹤0.01% 3295
2023
Q1 		$171K Buy
6,090
+12
+0.2% +$359 ﹤0.01% 3235
2022
Q4 		$137 Sell
6,078
-138
-2% -$3.15K ﹤0.01% 3287
2022
Q3 		$149K Buy
6,216
+3,450
+125% +$111K ﹤0.01% 3282
2022
Q2 		$80K Buy
+2,766
New +$124K ﹤0.01% 3355

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors's BNR Position: Q2 2024 in Review

Dimensional Fund Advisors sold out of Burning Rock Biotech (BNR) in Q2 2024, closing a stake of 4,902 shares — an estimated $35.7K sold.

Dimensional Fund Advisors first reported a position in BNR in Q2 2022 and held it in 8 quarters. The position peaked at $171K in Q1 2023. 18 funds tracked by Wall St. Rank hold BNR as of Q2 2024.

  • Dimensional Fund Advisors reported no remaining Burning Rock Biotech position as of Q2 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 4,902 Burning Rock Biotech shares in Q2 2024, an estimated $35.7K.
  • Dimensional Fund Advisors first reported a position in Burning Rock Biotech in Q2 2022 and held it in 8 quarters.
  • Dimensional Fund Advisors's Burning Rock Biotech position peaked at $171K in Q1 2023.
  • 18 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2024.

Based on Dimensional Fund Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.